Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
Status:
Completed
Trial end date:
2018-09-23
Target enrollment:
Participant gender:
Summary
Randomized double blind placebo controlled pilot study/proof of concept-study to see if
intradermal injection with Botulinum toxin B is an effective treatment of Hidradenitis
suppurativa
Phase:
N/A
Details
Lead Sponsor:
University Hospital of North Norway
Collaborators:
Hidrosis Clinic, Stockholm, Sweden The Royal Norwegian Ministry of Health
Treatments:
Botulinum Toxins Botulinum Toxins, Type A rimabotulinumtoxinB